Truist maintains Buy on Amentum stock, reiterates $31 target
Truist Securities sustained its optimistic stance on Amentum Holdings Inc. (NYSE:AMTM) following the company's release of favorable first-quarter 2025 results. With current revenue of $9.82 billion ...
Progyny (PGNY) Gets a Hold from Truist Financial
Truist Financial analyst Jailendra Singh maintained a Hold rating on Progyny (PGNY – Research Report) today and set a price target of $24.00.
Truist cuts Cargo Therapeutics rating, slashes PT to $7
Truist Securities revised its position on Cargo Therapeutics (NASDAQ:CRGX), currently trading at $13.19 with a market ...
Pacira upgraded to Hold from Sell at Truist
Truist upgraded Pacira (PCRX) to Hold from Sell with a price target of $25, up from $8. Following meetings with management, the firm is “more ...